Followers | 884 |
Posts | 80782 |
Boards Moderated | 2 |
Alias Born | 01/09/2006 |
Wednesday, October 17, 2018 11:25:20 AM
It’s a gold for @TheCleanSpace and @DigitalClarity in the ‘Best evaluation strategy’ category. Congratulations to them both! #DIAwards
It’s a gold for @TheCleanSpace and @DigitalClarity in the ‘Best evaluation strategy’ category. Congratulations to them both! #DIAwards
— Communicate Events (@Comms_Events) October 16, 2018
Reggie James on @DisruptiveLive Show
LIVE NOW >> #TimelineShow s1e1 - new Social Media and Marketing Show, w/ Reggie James, Rachel Mepham & John Webb#DisruptiveLIVE #Business #SocialMedia #Marketinghttps://t.co/nmU1hqUwoF
— Disruptive LIVE (@disruptivelive) July 25, 2018
Audited Super 10K https://backend.otcmarkets.com/otcapi/company/sec-filings/12787576/content/html
ALJ/SEC Case https://www.sec.gov/litigation/apdocuments/ap-3-17990.xml
Audited 3 year consolidated super 10k filed
Q1 filed, Q2 filed, Q3 filed
DBMM is current in their K & Q filings and is no longer listed as 'Delinquent SEC Filer'
Filings https://www.otcmarkets.com/stock/dbmm/disclosure
Asher lawsuit settled, case disposed! https://iapps.courts.state.ny.us/webcivil/FCASSearch id: 600717/2014
No OS changes since May 2016 (common or preferred).
Q2 shows 29% rev increase 6m period over period
Q3 shows 6% rev increase 9m period over period
$192k from wealth groups already provided (listed in audited super 10k)
$250k from wealth groups at bat (listed in audited super 10k)
$3m ROFR to round the bases for the bases loaded home run hit (listed in audited super 10k)
go dbmm go
Buy it, trade it, hold it, ignore it... do whatever your want, just
don't do it because of what I say as my posts are just my opinion.
Recent DBMM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:32:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 09:31:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 09:15:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM